From research and development to manufacturing, Corning is proud to offer the latest innovative technology to support your advanced therapy applications. From vaccine production to advanced therapy applications, Corning can supply the tools to get you there.
Our cell expansion platforms, from the new Ascent™ Fixed Bed Reactor (FBR) System to the trusted HYPER® and CellSTACK® technologies, are proven to increase efficiency in scale-up, while continuing to deliver reliability and reproducibility, resulting in increased cell viability and yield. Several of our platforms feature closed systems or automation—thereby reducing risk of contamination, variability, and human error.
Working with these tools supports efficient, successful scale-up, while reducing cost and speeding up time to market, providing a path for your research to translate from the lab to life changing treatments and therapies. Look to Corning’s years of experience in cell culture innovation and our team of field service experts to guide you along your journey to discovery.
